The DOI matches its Crossref record; 107 of the 107 references it cites were found in a registry or an index.
Progressive pulmonary fibrosis: an expert group consensus statement
Open accessAbstract
This expert group consensus statement emphasises the need for standardising the definition of progressive fibrosing interstitial lung diseases (F-ILDs), with an accurate initial diagnosis being of paramount importance in ensuring appropriate initial management. Equally, case-by-case decisions on monitoring and management are essential, given the varying presentations of F-ILDs and the varying rates of progression. The value of diagnostic tests in risk stratification at presentation and, separately, the importance of a logical monitoring strategy, tailored to manage the risk of progression, are also stressed. The term “progressive pulmonary fibrosis” (PPF) exactly describes the entity that clinicians often face in practice. The importance of using antifibrotic therapy early in PPF (once initial management has failed to prevent progression) is increasingly supported by evidence. Artificial intelligence software for high-resolution computed tomography analysis, although an exciting tool for the future, awaits validation. Guidance is provided on pulmonary rehabilitation, oxygen and the use of non-invasive ventilation focused specifically on the needs of ILD patients with progressive disease. PPF should be differentiated from acute deterioration due to drug-induced lung toxicity or other forms of acute exacerbations. Referral criteria for a lung transplant are discussed and applied to patient needs in severe diseases where transplantation is not realistic, either due to access limitations or transplantation contraindications. In conclusion, expert group consensus guidance is provided on the diagnosis, treatment and monitoring of F-ILDs with specific focus on the recognition of PPF and the management of pulmonary fibrosis progressing despite initial management.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Raghu, G., Collard, H. R., Egan, J. J., Martinez, F. J., Behr, J., Brown, K. K., Colby, T. V., Cordier, J.-F., Flaherty, K. R., Lasky, J. A., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2009-040gl · Cited by 7,186
Self-citationEfficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis
Richeldi, L., du Bois, R. M., Raghu, G., Azuma, A., Brown, K. K., Costabel, U., Cottin, V., Flaherty, K. R., Hansell, D. M., Inoue, Y., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1402584 · Cited by 4,654
Self-citationDiagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline
Raghu, G., Remy-Jardin, M., Myers, J. L., Richeldi, L., Ryerson, C. J., Lederer, D. J., Behr, J., Cottin, V., Danoff, S. K., Morell, F., et al. (2018) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201807-1255st · Cited by 4,103
Self-citationA phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis.
King, T. E., Bradford, W. Z., Castro-Bernardini, S., Fagan, E. A., Glaspole, I., Glassberg, M. K., Gorina, E., Hopkins, P. M., Kardatzke, D., Lancaster, L., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1402582 · Cited by 3,975
Raghu, G., Remy-Jardin, M., Richeldi, L., Thomson, C. C., Inoue, Y., Johkoh, T., Kreuter, M., Lynch, D. A., Maher, T. M., Martinez, F. J., et al. (2022) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202202-0399st · Cited by 2,957
Self-citationNintedanib in Progressive Fibrosing Interstitial Lung Diseases
Flaherty, K. R., Wells, A. U., Cottin, V., Devaraj, A., Walsh, S. L. F., Inoue, Y., Richeldi, L., Kolb, M., Tetzlaff, K., Stowasser, S., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1908681 · Cited by 2,403
Self-citationPirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials
Noble, P. W., Albera, C., Bradford, W. Z., Costabel, U., Glassberg, M. K., Kardatzke, D., King, T. E., Lancaster, L., Sahn, S. A., Szwarcberg, J., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60405-4 · Cited by 2,154
General considerations for lung function testing
Miller, M. R., Crapo, R., Hankinson, J., Brusasco, V., Burgos, F., Casaburi, R., Coates, A., Enright, P., Grinten, C. P. M. V. D., Gustafsson, P., et al. (2005) · European Respiratory Journal · doi:10.1183/09031936.05.00034505 · Cited by 2,026
American Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation
Nici, L., Donner, C., Wouters, E., Zuwallack, R., Ambrosino, N., Bourbeau, J., Carone, M., Celli, B., Engelen, M., Fahy, B., et al. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200508-1211st · Cited by 1,966
Nintedanib for systemic sclerosis–associated interstitial lung disease
Distler, O., Highland, K. B., Gahlemann, M., Azuma, A., Fischer, A., Mayes, M. D., Raghu, G., Sauter, W., Girard, M., Alves, M., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1903076 · Cited by 1,647
Acute Exacerbation of Idiopathic Pulmonary Fibrosis. An International Working Group Report
Collard, H. R., Ryerson, C. J., Corte, T. J., Jenkins, G., Kondoh, Y., Lederer, D. J., Lee, J. S., Maher, T. M., Wells, A. U., Antoniou, K. M., et al. (2016) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201604-0801ci · Cited by 1,444
Self-citationInterstitial Lung Disease in Systemic Sclerosis: A Simple Staging System
Goh, N. S. L., Desai, S. R., Veeraraghavan, S., Hansell, D. M., Copley, S. J., Maher, T. M., Corte, T. J., Sander, C. R., Ratoff, J., Devaraj, A., et al. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200706-877oc · Cited by 1,230
Self-citationEfficacy of a Tyrosine Kinase Inhibitor in Idiopathic Pulmonary Fibrosis
Richeldi, L., Costabel, U., Selman, M., Kim, D. S., Hansell, D. M., Nicholson, A. G., Brown, K. K., Flaherty, K. R., Noble, P. W., Raghu, G., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1103690 · Cited by 1,157
Self-citationRaghu, G., Remy-Jardin, M., Ryerson, C. J., Myers, J. L., Kreuter, M., Vasakova, M., Bargagli, E., Chung, J. H., Collins, B. F., Bendstrup, E., et al. (2020) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202005-2032st · Cited by 1,047
Self-citationDouble-blind, Placebo-controlled Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis
Azuma, A., Nukiwa, T., Tsuboi, E., Suga, M., Abe, S., Nakata, K., Taguchi, Y., Nagai, S., Itoh, H., Ohi, M., et al. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200404-571oc · Cited by 954
Interstitial lung disease guideline
Wells, A. U., Hirani, N., & on behalf of the BTS Interstitial Lung Disease Guideline Group, A. S. O. T. B. T. S. S. O. C. C. (2008) · Thorax · doi:10.1136/thx.2008.101691 · Cited by 866
Self-citationLeard, L. E., Holm, A. M., Valapour, M., Glanville, A. R., Attawar, S., Aversa, M., Campos, S. V., Christon, L. M., Cypel, M., Dellgren, G., et al. (2021) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2021.07.005 · Cited by 821
Spectrum of fibrotic lung diseases
Wijsenbeek, M., & Cottin, V. (2020) · New England Journal of Medicine · doi:10.1056/nejmra2005230 · Cited by 736
Self-citationWells, A. U., Desai, S. R., Rubens, M. B., Goh, N. S. L., Cramer, D., Nicholson, A. G., Colby, T. V., du Bois, R. M., & Hansell, D. M. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2111053 · Cited by 686
Self-citationCottin, V., Hirani, N. A., Hotchkin, D. L., Nambiar, A. M., Ogura, T., Otaola, M., Skowasch, D., Park, J. S., Poonyagariyagorn, H. K., Wuyts, W., et al. (2018) · European Respiratory Review · doi:10.1183/16000617.0076-2018 · Cited by 652
Self-citationMaher, T. M., Corte, T. J., Fischer, A., Kreuter, M., Lederer, D. J., Molina-Molina, M., Axmann, J., Kirchgaessler, K.-U., Samara, K., Gilberg, F., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(19)30341-8 · Cited by 629
Self-citationUsual interstitial pneumonia in rheumatoid arthritis-associated interstitial lung disease
Kim, E. J., Elicker, B. M., Maldonado, F., Webb, W. R., Ryu, J. H., Van Uden, J. H., Lee, J. S., King, T. E., & Collard, H. R. (2010) · European Respiratory Journal · doi:10.1183/09031936.00092309 · Cited by 587
Wells, A. U., Flaherty, K. R., Brown, K. K., Inoue, Y., Devaraj, A., Richeldi, L., Moua, T., Crestani, B., Wuyts, W. A., Stowasser, S., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30036-9 · Cited by 569
Self-citationdu Bois, R. M., Weycker, D., Albera, C., Bradford, W. Z., Costabel, U., Kartashov, A., King, T. E., Lancaster, L., Noble, P. W., Sahn, S. A., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201105-0840oc · Cited by 527
Self-citationBehr, J., Prasse, A., Kreuter, M., Johow, J., Rabe, K. F., Bonella, F., Bonnet, R., Grohe, C., Held, M., Wilkens, H., et al. (2021) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30554-3 · Cited by 522
Abernethy, A. P., McDonald, C. F., Frith, P. A., Clark, K., Herndon, J. E., Marcello, J., Young, I. H., Bull, J., Wilcock, A., Booth, S., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61115-4 · Cited by 495
Self-citationPredictors of mortality in rheumatoid arthritis-associated interstitial lung disease
Solomon, J. J., Chung, J. H., Cosgrove, G. P., Demoruelle, M. K., Fernandez-Perez, E. R., Fischer, A., Frankel, S. K., Hobbs, S. B., Huie, T. J., Ketzer, J., et al. (2016) · European Respiratory Journal · doi:10.1183/13993003.00357-2015 · Cited by 388
Self-citationZappala, C. J., Latsi, P. I., Nicholson, A. G., Colby, T. V., Cramer, D., Renzoni, E. A., Hansell, D. M., du Bois, R. M., & Wells, A. U. (2010) · European Respiratory Journal · doi:10.1183/09031936.00155108 · Cited by 372
Self-citationIdiopathic Interstitial Pneumonias: Diagnostic Accuracy of Thin-Section CT in 129 Patients
Johkoh, T., Müller, N. L., Cartier, Y., Kavanagh, P. V., Hartman, T. E., Akira, M., Ichikado, K., Ando, M., & Nakamura, H. (1999) · Radiology · doi:10.1148/radiology.211.2.r99ma01555 · Cited by 356
Goh, N. S., Hoyles, R. K., Denton, C. P., Hansell, D. M., Renzoni, E. A., Maher, T. M., Nicholson, A. G., & Wells, A. U. (2017) · Arthritis & Rheumatology · doi:10.1002/art.40130 · Cited by 354
Self-citationWhat's in a name? That which we call IPF, by any other name would act the same
Wells, A. U., Brown, K. K., Flaherty, K. R., Kolb, M., & Thannickal, V. J. (2018) · European Respiratory Journal · doi:10.1183/13993003.00692-2018 · Cited by 352
Self-citationGeorge, P. M., Spagnolo, P., Kreuter, M., Altinisik, G., Bonifazi, M., Martinez, F. J., Molyneaux, P. L., Renzoni, E. A., Richeldi, L., Tomassetti, S., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30355-6 · Cited by 349
Self-citationFibrosing interstitial lung diseases: knowns and unknowns
Cottin, V., Wollin, L., Fischer, A., Quaresma, M., Stowasser, S., & Harari, S. (2019) · European Respiratory Review · doi:10.1183/16000617.0100-2018 · Cited by 336
Self-citationBritish Thoracic Society guidelines for home oxygen use in adults: accredited by NICE
Hardinge, M., Annandale, J., Bourne, S., Cooper, B., Evans, A., Freeman, D., Green, A., Hippolyte, S., Knowles, V., MacNee, W., et al. (2015) · Thorax · doi:10.1136/thoraxjnl-2015-206865 · Cited by 327
Jacobs, S. S., Krishnan, J. A., Lederer, D. J., Ghazipura, M., Hossain, T., Tan, A.-Y. M., Carlin, B., Drummond, M. B., Ekström, M., Garvey, C., et al. (2020) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202009-3608st · Cited by 318
Self-citationPrevalence and prognosis of unclassifiable interstitial lung disease
Ryerson, C. J., Urbania, T. H., Richeldi, L., Mooney, J. J., Lee, J. S., Jones, K. D., Elicker, B. M., Koth, L. L., King, T. E., Wolters, P. J., et al. (2013) · European Respiratory Journal · doi:10.1183/09031936.00131912 · Cited by 310
Lung transplantation for idiopathic pulmonary fibrosis
George, P. M., Patterson, C. M., Reed, A. K., & Thillai, M. (2019) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(18)30502-2 · Cited by 297
Khanna, D., Albera, C., Fischer, A., Khalidi, N., Raghu, G., Chung, L., Chen, D., Schiopu, E., Tagliaferri, M., Seibold, J. R., et al. (2016) · The Journal of Rheumatology · doi:10.3899/jrheum.151322 · Cited by 268
Usual interstitial pneumonia: histologic correlation with high-resolution CT.
Nishimura, K., Kitaichi, M., Izumi, T., Nagai, S., Kanaoka, M., & Itoh, H. (1992) · Radiology · doi:10.1148/radiology.182.2.1732946 · Cited by 267
Progressive fibrosing interstitial lung diseases: current practice in diagnosis and management
Wijsenbeek, M., Kreuter, M., Olson, A., Fischer, A., Bendstrup, E., Wells, C. D., Denton, C. P., Mounir, B., Zouad-Lejour, L., Quaresma, M., et al. (2019) · Current Medical Research and Opinion · doi:10.1080/03007995.2019.1647040 · Cited by 261
Self-citationdu Bois, R. M., Albera, C., Bradford, W. Z., Costabel, U., Leff, J. A., Noble, P. W., Sahn, S. A., Valeyre, D., Weycker, D., & King, T. E. (2014) · European Respiratory Journal · doi:10.1183/09031936.00131813 · Cited by 246
Visca, D., Mori, L., Tsipouri, V., Fleming, S., Firouzi, A., Bonini, M., Pavitt, M. J., Alfieri, V., Canu, S., Bonifazi, M., et al. (2018) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(18)30289-3 · Cited by 235
Self-citationJo, H. E., Glaspole, I., Grainge, C., Goh, N., Hopkins, P. M. A., Moodley, Y., Reynolds, P. N., Chapman, S., Walters, E. H., Zappala, C., et al. (2017) · European Respiratory Journal · doi:10.1183/13993003.01592-2016 · Cited by 233
Walsh, S. L. F., Sverzellati, N., Devaraj, A., Keir, G. J., Wells, A. U., & Hansell, D. M. (2014) · Thorax · doi:10.1136/thoraxjnl-2013-203843 · Cited by 229
Self-citationProgressive fibrosing interstitial lung disease: a clinical cohort (the PROGRESS study)
Nasser, M., Larrieu, S., Si-Mohamed, S., Ahmad, K., Boussel, L., Brevet, M., Chalabreysse, L., Fabre, C., Marque, S., Revel, D., et al. (2021) · European Respiratory Journal · doi:10.1183/13993003.02718-2020 · Cited by 217
Self-citationHighland, K. B., Distler, O., Kuwana, M., Allanore, Y., Assassi, S., Azuma, A., Bourdin, A., Denton, C. P., Distler, J. H. W., Hoffmann-Vold, A. M., et al. (2021) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30330-1 · Cited by 217
Safety and pharmacokinetics of nintedanib and pirfenidone in idiopathic pulmonary fibrosis
Ogura, T., Taniguchi, H., Azuma, A., Inoue, Y., Kondoh, Y., Hasegawa, Y., Bando, M., Abe, S., Mochizuki, Y., Chida, K., et al. (2015) · European Respiratory Journal · doi:10.1183/09031936.00198013 · Cited by 215
Progressive Decline of Lung Function in Rheumatoid Arthritis–Associated Interstitial Lung Disease
Zamora‐Legoff, J. A., Krause, M. L., Crowson, C. S., Ryu, J. H., & Matteson, E. L. (2017) · Arthritis & Rheumatology · doi:10.1002/art.39971 · Cited by 215
Pirfenidone Reduces Respiratory-related Hospitalizations in Idiopathic Pulmonary Fibrosis
Ley, B., Swigris, J., Day, B.-M., Stauffer, J. L., Raimundo, K., Chou, W., & Collard, H. R. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201701-0091oc · Cited by 206
Body Mass Index and Mortality in Patients With Idiopathic Pulmonary Fibrosis
Alakhras, M., Decker, P. A., Nadrous, H. F., Collazo-Clavell, M., & Ryu, J. H. (2007) · Chest · doi:10.1378/chest.06-2784 · Cited by 186
Progression of fibrosing interstitial lung disease
Wong, A. W., Ryerson, C. J., & Guler, S. A. (2020) · Respiratory Research · doi:10.1186/s12931-020-1296-3 · Cited by 185
Change in FVC and survival in chronic fibrotic hypersensitivity pneumonitis
Gimenez, A., Storrer, K., Kuranishi, L., Soares, M. R., Ferreira, R. G., & Pereira, C. A. C. (2018) · Thorax · doi:10.1136/thoraxjnl-2017-210035 · Cited by 184
Quantitative Computed Tomography Imaging of Interstitial Lung Diseases
Bartholmai, B. J., Raghunath, S., Karwoski, R. A., Moua, T., Rajagopalan, S., Maldonado, F., Decker, P. A., & Robb, R. A. (2013) · Journal of Thoracic Imaging · doi:10.1097/rti.0b013e3182a21969 · Cited by 179
Brighton, L. J., Miller, S., Farquhar, M. C., Booth, S., Yi, D., Gao, W., Bajwah, S., Man, W. D., Higginson, I. J., & Maddocks, M. M. (2018) · Thorax · doi:10.1136/thoraxjnl-2018-211589 · Cited by 157
Role and New Insights of Pirfenidone in Fibrotic Diseases
la Mora, D. A. L.-D., Sánchez-Roque, C., Montoya‐Buelna, M., Sánchez‐Enríquez, S., Lucano‐Landeros, S., Macías‐Barragán, J., & Armendáriz‐Borunda, J. (2015) · International Journal of Medical Sciences · doi:10.7150/ijms.11579 · Cited by 150
Lung function trajectory in progressive fibrosing interstitial lung disease
Oldham, J. M., Lee, C. T., Wu, Z., Bowman, W. S., Pugashetti, J. V., Đao, N. H., Tonkin, J., Seede, H., Echt, G., Adegunsoye, A., et al. (2021) · European Respiratory Journal · doi:10.1183/13993003.01396-2021 · Cited by 138
Ley, B., Torgerson, D. G., Oldham, J. M., Adegunsoye, A., Liu, S., Li, J., Elicker, B. M., Henry, T. S., Golden, J. A., Jones, K. D., et al. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201902-0360oc · Cited by 135
Inoue, Y., Kaner, R. J., Guiot, J., Maher, T. M., Tomassetti, S., Moiseev, S., Kuwana, M., & Brown, K. K. (2020) · Chest · doi:10.1016/j.chest.2020.03.037 · Cited by 133
Self-citationWest Japan Oncology Group, Iwata, T., Yoshino, I., Yoshida, S., Ikeda, N., Tsuboi, M., Asato, Y., Katakami, N., Sakamoto, K., Yamashita, Y., et al. (2016) · Respiratory Research · doi:10.1186/s12931-016-0398-4 · Cited by 122
Kronzer, V. L., Huang, W., Dellaripa, P. F., Huang, S., Feathers, V. L., Lü, B., Iannaccone, C. K., Gill, R. R., Hatabu, H., Nishino, M., et al. (2020) · The Journal of Rheumatology · doi:10.3899/jrheum.200863 · Cited by 113
Guler, S. A., Winstone, T. A., Murphy, D. T., Hague, C. J., Soon, J., Sulaiman, N., Li, K. H., Dunne, J. V., Wilcox, P., & Ryerson, C. J. (2018) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201806-362oc · Cited by 111
Udwadia, Z., Koul, P. A., & Richeldi, L. (2020) · Lung India · doi:10.4103/lungindia.lungindia_818_20 · Cited by 110
Self-citationReiseter, S., Gunnarsson, R., Aaløkken, T. M., Lund, M. B., Mynarek, G. K., Corander, J., Haydon, J., & Molberg, Ø. (2017) · Lara D. Veeken · doi:10.1093/rheumatology/kex077 · Cited by 109
Lung transplantation for interstitial lung disease
Kapnadak, S. G., & Raghu, G. (2021) · European Respiratory Review · doi:10.1183/16000617.0017-2021 · Cited by 109
Gouellec, N. L., Duhamel, A., Perez, T., Hachulla, A.-L., Sobanski, V., Faivre, J., Morell‐Dubois, S., Lambert, M., Hatron, P., HACHULLA, E., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0181692 · Cited by 108
Kato, M., Sasaki, S., Nakamura, T., Kurokawa, K., Yamada, T., Ochi, Y., Ihara, H., Takahashi, F., & Takahashi, K. (2019) · Scientific Reports · doi:10.1038/s41598-019-48593-4 · Cited by 106
Indications, patient selection and timing of referral for lung transplantation
Glanville, A. R., & Estenne, M. (2003) · European Respiratory Journal · doi:10.1183/09031936.03.00039003 · Cited by 101
Diagnosis and management of idiopathic pulmonary fibrosis: French practical guidelines
Cottin, V., Crestani, B., Valeyre, D., Wallaert, B., Cadranel, J. L., Dalphin, J., Delaval, P., Israël‐Biet, D., Kessler, R., Reynaud‐Gaubert, M., et al. (2014) · European Respiratory Review · doi:10.1183/09059180.00001814 · Cited by 96
Self-citationDhooria, S., Agarwal, R., Sehgal, I. S., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0191938 · Cited by 87
Self-citationReichmann, W. M., Yu, Y., Macaulay, D. S., Wu, E. Q., & Nathan, S. D. (2015) · BMC Pulmonary Medicine · doi:10.1186/s12890-015-0161-5 · Cited by 85
The burden of progressive fibrotic interstitial lung disease across the UK
Simpson, T., Barratt, S. L., Beirne, P., Chaudhuri, N., Crawshaw, A., Crowley, L., Fletcher, S., Gibbons, M., Hallchurch, P., Horgan, L., et al. (2021) · European Respiratory Journal · doi:10.1183/13993003.00221-2021 · Cited by 81
Jee, A. S., Adelstein, S., Bleasel, J. F., Keir, G. J., Nguyen, M., Sahhar, J., Youssef, P. P., & Corte, T. J. (2017) · Journal of Clinical Medicine · doi:10.3390/jcm6050051 · Cited by 80
Cottin, V. (2019) · European Respiratory Review · doi:10.1183/16000617.0109-2019 · Cited by 79
Self-citationDistler, O., Brown, K. K., Distler, J. H. W., Assassi, S., Maher, T. M., Cottin, V., Varga, J., Coeck, C., Gahlemann, M., Sauter, W., et al. (2017) · PubMed · Cited by 74
Self-citationNintedanib and immunomodulatory therapies in progressive fibrosing interstitial lung diseases
Cottin, V., Richeldi, L., Rosas, I. O., Otaola, M., Song, J. W., Tomassetti, S., Wijsenbeek, M. S., Schmitz, M., Coeck, C., Stowasser, S., et al. (2021) · Respiratory Research · doi:10.1186/s12931-021-01668-1 · Cited by 74
Self-citationInterstitial lung disease in systemic sclerosis: data from the spanish scleroderma study group
Sánchez‐Cano, D., Ortego‐Centeno, N., Callejas-Rubio, J. L., Fonollosa‐Pla, V., Ríos-Fernández, R., Tolosa-Vilella, C., Espinosa, G., Colunga-Argüelles, D., Egurbide-Arberas, M. V., Rubio‐Rivas, M., et al. (2018) · Rheumatology International · doi:10.1007/s00296-017-3916-x · Cited by 70
Lung Transplantation in Idiopathic Pulmonary Fibrosis
Hernández, R. L., Pérez, M. A., Mt, L.-C., & Gil, P. U. (2018) · Medical Sciences · doi:10.3390/medsci6030068 · Cited by 68
Faverio, P., Piluso, M., Giacomi, F. D., Zoppa, M. D., Cassandro, R., Harari, S. A., Luppi, F., & Pesci, A. (2020) · Respiration · doi:10.1159/000509556 · Cited by 68
Wells, A. U. (2012) · Thorax · doi:10.1136/thoraxjnl-2012-202640 · Cited by 66
Self-citationMaher, T. M., Corte, T. J., Fischer, A., Kreuter, M., Lederer, D. J., Molina‐Molina, M., Axmann, J., Kirchgaessler, K.-U., & Cottin, V. (2018) · BMJ Open Respiratory Research · doi:10.1136/bmjresp-2018-000289 · Cited by 59
Self-citationHoffmann‐Vold, A., Weigt, S. S., Saggar, R., Palchevskiy, V., Volkmann, E. R., Liang, L. L., Ross, D. J., Ardehali, A. A., Lynch, J. P., & Belperio, J. A. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.10.050 · Cited by 58
Patolia, S., Kakazu, M. T., Chami, H. A., et al. (2020) · Annals of the American Thoracic Society · doi:10.1513/annalsats.202005-420oc · Cited by 58
Lung biopsy in interstitial lung disease: balancing the risk of surgery and diagnostic uncertainty
Cottin, V. (2016) · European Respiratory Journal · doi:10.1183/13993003.01633-2016 · Cited by 57
Self-citationPiciucchi, S., Tomassetti, S., Ravaglia, C., Gurioli, C., Gurioli, C., Dubini, A., Carloni, A., Chilosi, M., Colby, T. V., & Poletti, V. E. (2016) · BMC Pulmonary Medicine · doi:10.1186/s12890-016-0245-x · Cited by 56
Self-citationLee, S. H., Park, J. S., Kim, S. Y., Kim, D. S., Kim, Y. W., Chung, M. P., Uh, S. T., Park, C. S., Park, S. W., Jeong, S. H., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-23073-3 · Cited by 50
Gulati, S., & Luckhardt, T. (2020) · Drug Healthcare and Patient Safety · doi:10.2147/dhps.s224007 · Cited by 48
Kapalabhati Pranayama: Breath of Fire or Cause of Pneumothorax?
Johnson, D. B., Tierney, M. J., & Sadighi, P. J. (2004) · CHEST Journal · doi:10.1378/chest.125.5.1951 · Cited by 47
Ryerson, C. J., Corte, T. J., Myers, J. L., Walsh, S. L. F., & Guler, S. A. (2021) · European Respiratory Journal · doi:10.1183/13993003.00276-2021 · Cited by 47
Pirfenidone: antifibrotic agent for idiopathic pulmonary fibrosis
Azuma, A. (2010) · Expert Review of Respiratory Medicine · doi:10.1586/ers.10.32 · Cited by 44
Graney, B. A., & Lee, J. S. (2018) · Patient Related Outcome Measures · doi:10.2147/prom.s144425 · Cited by 42
Importance of chest HRCT in the diagnostic evaluation of fibrosing interstitial lung diseases
Torres, P. P. T. E. S., Rabahi, M. F., Moreira, M. A. C., Escuissato, D. L., Meirelles, G. D. S. P., & Marchiori, E. D. S. (2021) · Jornal Brasileiro de Pneumologia · doi:10.36416/1806-3756/e20200096 · Cited by 42
Hwang, J.-H., Misumi, S., Curran‐Everett, D., Brown, K. K., Şahin, H., & Lynch, D. A. (2010) · Journal of Thoracic Imaging · doi:10.1097/rti.0b013e3181e35823 · Cited by 38
Self-citationOxygen therapy in COPD and interstitial lung disease: navigating the knowns and unknowns
Khor, Y. H., Renzoni, E. A., Visca, D., et al. (2019) · ERJ Open Research · doi:10.1183/23120541.00118-2019 · Cited by 37
Self-citationIdiopathic Pulmonary Fibrosis in Switzerland: Diagnosis and Treatment
Funke-Chambour, M., Azzola, A., Adler, D., Barazzone‐Argiroffo, C., Benden, C., Boehler, A., Bridevaux, P., Brutsche, M. H., Clarenbach, C. F., Hostettler, K., et al. (2017) · Respiration · doi:10.1159/000464332 · Cited by 36
Palliative Use of Noninvasive Ventilation: Navigating Murky Waters
Quill, C. M., & Quill, T. E. (2014) · Journal of Palliative Medicine · doi:10.1089/jpm.2014.0010 · Cited by 35
Khan, T., José, R. J. P., Renzoni, E. A., & Mouyis, M. (2021) · Rheumatology and Therapy · doi:10.1007/s40744-021-00362-4 · Cited by 35
Self-citationBattery operated fan and chronic breathlessness: does it help?
Barnes-Harris, M., Allgar, V. L., Booth, S., Currow, D. C., Hart, S. P., Phillips, J. L., Swan, F., & Johnson, M. J. (2019) · BMJ Supportive & Palliative Care · doi:10.1136/bmjspcare-2018-001749 · Cited by 34
Self-citationLung Transplantation for Idiopathic Pulmonary Fibrosis
Lamas, D. J., & Lederer, D. J. (2013) · Humana Press eBooks · doi:10.1007/978-1-62703-682-5_18 · Cited by 32
Long-Term Oxygen Therapy: Comparison of the German and British Guidelines
Magnet, F. S., Schwarz, S. B., Callegari, J., Criée, C.-P., Storre, J. H., & Windisch, W. (2017) · Respiration · doi:10.1159/000455879 · Cited by 32
Moderno, E. V., Yamaguti, W. P. S., Schettino, G. P. P., Kairalla, R. A., Martins, M. A., de Carvalho, C. R. R., & Carvalho, C. R. F. (2009) · Respiratory Medicine · doi:10.1016/j.rmed.2009.08.001 · Cited by 26
Koczulla, A. R., Schneeberger, T., Jarosch, I., Kenn, K., & Gloeckl, R. (2018) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2018.0871 · Cited by 26
Kolonics-Farkas, A. M., Šterclová, M., Moğulkoç, N., Kuś, J., Hájková, M., Müller, V., Jovanović, D. M., Tekavec-Trkanjec, J., Littnerová, S., Hejduk, K., et al. (2020) · Drug Safety · doi:10.1007/s40264-020-00978-5 · Cited by 24
State of the art in the diagnosis and management of interstitial lung disease
Wetscherek, M. T., & Pop, C. M. (2015) · Medicine and Pharmacy Reports · doi:10.15386/cjmed-457 · Cited by 14
Antifibrotic drugs for idiopathic pulmonary fibrosis: What we should know?
Hadda, V., & Guleria, R. (2020) · The Indian Journal of Medical Research · doi:10.4103/ijmr.ijmr_90_20 · Cited by 14
Takizawa, A., Kamita, M., Kondoh, Y., Bando, M., Kuwana, M., & Inoue, Y. (2020) · Current Medical Research and Opinion · doi:10.1080/03007995.2020.1860920 · Cited by 14
The emerging role of mycophenolate mofetil in interstitial lung diseases
Brown, K. K., Rajan, S. K., Shenoy, P. D., Mehta, M., Lopez, M., Hegde, R. S., & Gogtay, J. A. (2021) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2021.2001331 · Cited by 13
Self-citationWells, A. U. (2021) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(21)00173-9 · Cited by 7
Self-citation
Cited by
Pulmonary fibrosis: from pathogenesis to clinical decision-making
Koudstaal, T., Funke-Chambour, M., Kreuter, M., Molyneaux, P. L., & Wijsenbeek, M. S. (2023) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2023.08.010 · Cited by 256
Zou, M., Hu, X., Song, W., Gao, H., Wu, C., Zheng, W., & Cheng, Z. (2023) · Clinical and Experimental Medicine · doi:10.1007/s10238-023-01214-x · Cited by 10
Kolb, M., Corte, T. J., Feldman, J., Nathan, S. D., Reisner, C., Nair, D., Woodhead, F., Lazarus, H., & Conoscenti, C. (2025) · BMJ Open Respiratory Research · doi:10.1136/bmjresp-2024-003059 · Cited by 1
Self-citation
Metadata
- Authors
- Rajan, S. K., Cottin, V., Dhar, R., Danoff, S., Flaherty, K. R., Brown, K. K., Mohan, A., Renzoni, E., Mohan, M., Udwadia, Z., Shenoy, P., Currow, D., Devraj, A., Jankharia, B., Kulshrestha, R., Jones, S., Ravaglia, C., Quadrelli, S., Iyer, R., Dhooria, S., Kolb, M., & Wells, A. U.
- Venue
- European Respiratory Journal
- Publisher
- European Respiratory Society (ERS)
- Published
- 2022-12-14
- Volume
- 61
- Issue
- 3
- Pages
- 2103187
- ISSN
- 0903-1936 (ISSN-L)
- 1399-3003
- OpenAlex
- W4311487211
- Cited by
- 258
- References
- 107
- FWCI
- 28.05
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.